Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Undergraduate School

Boston College

1992, Boston, MA

Medical School

University of Vermont Medical School

1996, Burlington, VT

Internship

Duke University

1997, Durham, NC

Residency

Duke University

2000, Durham, NC

Fellowship

Duke University

2006, Durham, NC

Certifications

  • American Board of Internal Medicine (Adult Congenital Heart Disease)

Professional History

Dr. Valente completed residency in Internal Medicine and Pediatrics, and fellowships in pediatric cardiology and adult cardiovascular disease, including advanced training in cardiac imaging at Duke University Medical Center. Dr. Valente is the director of the Boston Adult Congenital Heart (BACH) program. She is currently a member of the Non-Invasive Division in the Department of Cardiology at Boston Children's Hospital specializing in cardiac magnetic resonance imaging. Her research interests focus primarily on identifying non-invasive risk factors in patients with complex congenital heart disease; much of her work involves patients with repaired tetralogy of Fallot (TOF), including leading an international registry (INDICATOR) of TOF patients.

Dr. Valente is a founding member of the Alliance for Adult Research in Congenital Cardiology Group and has been involved in multi-center trials in adults with congenital heart disease. Additionally, Dr. Valente co-directs the Pregnancy and Cardiovascular Disease Program at the Brigham and Women’s Hospital and leads several investigations in women with congenital heart disease during pregnancy. She serves on multiple regional and national committees, including the American College of Cardiology and the American Heart Association.

Media

Caregiver Profile

Meet Dr. Anne Marie Valente

Publications

  1. Double double, future trouble? Opportunities for cardio-obstetric collaboration to reduce future cardiovascular events following twin pregnancies. Eur Heart J. 2025 Apr 01; 46(13):1229-1231. View Abstract

  2. Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation. JACC Adv. 2025 Apr; 4(4):101646. View Abstract

  3. Electrocardiogram-based deep learning to predict mortality in paediatric and adult congenital heart disease. Eur Heart J. 2025 Mar 03; 46(9):856-868. View Abstract

  4. Acute Effects of Enhanced External Counterpulsation in Adults With Fontan Circulation. JACC Adv. 2025 Mar; 4(3):101591. View Abstract

  5. Ventricular-arterial coupling is associated with clinical outcomes in patients with systemic right ventricle. Am Heart J. 2025 Jul; 285:29-38. View Abstract

  6. Artificial Intelligence-Enabled Electrocardiogram Predicts Sudden Cardiac Death in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol. 2025 Mar; 11(3):593-595. View Abstract

  7. Electrocardiographic Changes in Pregnant Patients With Congenital Heart Disease Ann Noninvasive Electrocardiol. 2025 01; 30(1):e70037. View Abstract

  8. Propensity Score Analysis of Possible Medication Effects on Outcomes in Patients With Systemic Right Ventricles. JACC Adv. 2025 Jan; 4(1):101443. View Abstract

  9. Atrial Fibrillation in Heart Failure Due to Congenial Heart Disease. Card Electrophysiol Clin. 2025 Mar; 17(1):109-124. View Abstract

  10. Electrocardiogram-Based Deep Learning to Predict Mortality in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol. 2024 Dec; 10(12):2600-2612. View Abstract

  11. Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease. J Am Coll Cardiol. 2024 Aug 27; 84(9):815-828. View Abstract

  12. Life and Death: A Multicenter Study Evaluating Cardiologists' Approach to Difficult Conversations with Fontan Patients and Families. Pediatr Cardiol. 2024 Aug 20. View Abstract

  13. Development and Validation of a Mortality Risk Score for Repaired Tetralogy of Fallot. J Am Heart Assoc. 2024 Jun 18; 13(12):e034871. View Abstract

  14. The effects of pregnancy in subjects with repaired tetralogy of Fallot. Am Heart J. 2024 08; 274:95-101. View Abstract

  15. Hepatocellular carcinoma in survivors after Fontan operation: a case-control study. Eur Heart J. 2024 Apr 21; 45(16):1477-1480. View Abstract

  16. Home-based fitness training: chicken soup for the ACHD soul? Eur Heart J. 2024 Apr 21; 45(16):1474-1476. View Abstract

  17. Tempering the Storm of Arrhythmias in Adults With Congenital Heart Disease. J Am Heart Assoc. 2024 May 07; 13(9):e9566. View Abstract

  18. Addressing Psychologic Distress in Adults With Congenital Heart Disease: Replacing Anxiety With Hope. J Am Coll Cardiol. 2024 01 23; 83(3):442-443. View Abstract

  19. Competency based curriculum for cardiovascular magnetic resonance: A position statement of the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson. 2024; 26(1):100006. View Abstract

  20. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024 01 02; 83(1):109-279. View Abstract

  21. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 01 02; 149(1):e1-e156. View Abstract

  22. How Good Are Cardiologists at Predicting Major Adverse Events in Fontan Patients? JACC Adv. 2024 Jan; 3(1):100736. View Abstract

  23. Mobile Cardiac Telemetry Use to Predict Adverse Pregnancy Outcomes in Patients With Congenital Heart Disease. JACC Adv. 2023 Oct; 2(8):100593. View Abstract

  24. Patterns in hospital admissions for adults with congenital heart disease for non-cardiac procedures. Open Heart. 2023 09; 10(2). View Abstract

  25. Pericarditis Management in Individuals Contemplating Pregnancy, Currently Pregnant, or Breastfeeding. Curr Cardiol Rep. 2023 10; 25(10):1103-1111. View Abstract

  26. Ebstein Anomaly: More Than Just a Tricuspid Valve Issue. J Am Coll Cardiol. 2023 08 08; 82(6):514-516. View Abstract

  27. Pregnancies Complicated by Diabetes and Effect on Fetal Growth in Patients With Congenital Heart Disease. JACC Adv. 2023 Jul; 2(5):100406. View Abstract

  28. Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation. J Am Coll Cardiol. 2023 06 06; 81(22):2149-2160. View Abstract

  29. Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation. J Am Coll Cardiol. 2023 06 06; 81(22):2161-2171. View Abstract

  30. Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot. J Am Coll Cardiol. 2023 05 30; 81(21):2075-2085. View Abstract

  31. Cardiac Complications of Pregnancy in Desmoplakin Cardiomyopathy. JACC Case Rep. 2023 Jun 21; 16:101880. View Abstract

  32. Common congenital heart problems in acute and intensive care. Eur Heart J Acute Cardiovasc Care. 2023 Apr 17; 12(4):267-279. View Abstract

  33. Moderate intensity exercise in pregnant patients with cardiovascular disease: A pilot study. Am Heart J. 2023 08; 262:66-74. View Abstract

  34. Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure: Current Status and Potential Interventions. Heart Fail Clin. 2023 Jul; 19(3):345-356. View Abstract

  35. Tricuspid Regurgitation in Patients with Tetralogy of Fallot. J Clin Med. 2023 Mar 24; 12(7). View Abstract

  36. Half a century of experience with congenital heart disease: what have we learned about ventricular septal defects? Eur Heart J. 2023 01 01; 44(1):62-63. View Abstract

  37. Priorities and Understanding of Pregnancy Among Women With Congenital Heart Disease: A Mixed-Methods Study. JACC Adv. 2022 Oct; 1(4):100112. View Abstract

  38. Perioperative Anesthetic Management of the Pregnant Patient With Congenital Heart Disease Undergoing Cardiac Intervention: A Systematic Review. J Cardiothorac Vasc Anesth. 2022 12; 36(12):4483-4495. View Abstract

  39. Dyslipidemia Among Adults With Congenital Heart Disease. JACC Adv. 2022 Oct; 1(4):100081. View Abstract

  40. Congenitally Corrected Transposition of the Great Arteries in the Adult. Braz J Cardiovasc Surg. 2022 08 16; 37(4):534-545. View Abstract

  41. Placental Findings in Pregnancies Complicated by Maternal Cardiovascular Disease. JACC Adv. 2022 Mar; 1(1):100008. View Abstract

  42. The Association of Lower Venous Disease to Outcomes in Adults With Fontan Physiology: CALF Revisited. JACC Adv. 2022 Mar; 1(1):100002. View Abstract

  43. Serial cardiac biomarker assessment in adults with congenital heart disease hospitalized for decompensated heart failure?. Int J Cardiol Congenit Heart Dis. 2022 Mar; 7. View Abstract

  44. Cardiac MRI predictors of good long-term outcomes in patients with repaired TOF. Am Heart J. 2022 03; 245:70-77. View Abstract

  45. AHA/ACC vs ESC Guidelines for Management of Adults With Congenital Heart Disease: JACC Guideline Comparison. J Am Coll Cardiol. 2021 11 09; 78(19):1904-1918. View Abstract

  46. Don't be alarmed: the need for enhanced partnerships between medical communities to improve outcomes for adults living with congenital heart disease. Eur Heart J. 2021 11 01; 42(41):4249-4251. View Abstract

  47. Management of acute cardiovascular complications in pregnancy. Eur Heart J. 2021 11 01; 42(41):4224-4240. View Abstract

  48. Associations Between Clinical Outcomes and a Recently Proposed Adult Congenital Heart Disease Anatomic and Physiological Classification System. J Am Heart Assoc. 2021 09 21; 10(18):e021345. View Abstract

  49. Burden of compensated and decompensated cirrhosis: real world data from an Italian population-based cohort study. Eur Rev Med Pharmacol Sci. 2021 Jul; 25(13):4490-4498. View Abstract

  50. Reaching consensus for unified medical language in Fontan care. ESC Heart Fail. 2021 10; 8(5):3894-3905. View Abstract

  51. Transcatheter Aortic Valve Replacement in a Young Patient With Mandibuloacral Dysplasia. JACC Case Rep. 2021 Jun; 3(6):897-899. View Abstract

  52. Impact of pulmonary valve replacement on left ventricular rotational mechanics in repaired tetralogy of Fallot. J Cardiovasc Magn Reson. 2021 05 24; 23(1):61. View Abstract

  53. Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR). J Cardiovasc Magn Reson. 2021 05 10; 23(1):52. View Abstract

  54. The impact of pulmonary valve replacement on pregnancy outcomes in women with tetralogy of Fallot. Int J Cardiol. 2021 05 01; 330:43-49. View Abstract

  55. Timing of Delivery in Women with Cardiac Disease. Am J Perinatol. 2022 08; 39(11):1196-1203. View Abstract

  56. Intraperitoneal corticosteroids for recurrent ascites in patients with Fontan circulation: Initial clinical experience. J Card Surg. 2021 Feb; 36(2):735-738. View Abstract

  57. Bleeding and thrombotic risk in pregnant women with Fontan physiology. Heart. 2021 09; 107(17):1390-1397. View Abstract

  58. Long-Term Fate of the Truncal Valve. J Am Heart Assoc. 2020 11 17; 9(22):e019104. View Abstract

  59. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease: A Report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Soc Echocardiogr. 2020 10; 33(10):e1-e48. View Abstract

  60. Cardiovascular disease in women: insights from magnetic resonance imaging. J Cardiovasc Magn Reson. 2020 09 28; 22(1):71. View Abstract

  61. Impact of Pregnancy on Ventricular Strain in Women with Repaired Tetralogy of Fallot. Pediatr Cardiol. 2020 Dec; 41(8):1795-1799. View Abstract

  62. Interobserver agreement of the anatomic and physiological classification system for adult congenital heart disease. Am Heart J. 2020 11; 229:92-99. View Abstract

  63. Cardiovascular outcomes of pregnancy in Turner syndrome. Heart. 2021 01; 107(1):61-66. View Abstract

  64. The Second Time Around: Reinterventions for Transcatheter Pulmonary Valves. JACC Cardiovasc Interv. 2020 07 13; 13(13):1541-1543. View Abstract

  65. Pregnancy as a Cardiac Stress Test: Time to Include Obstetric History in Cardiac Risk Assessment? J Am Coll Cardiol. 2020 07 07; 76(1):68-71. View Abstract

  66. Transcatheter Pulmonary Valve Performance During Pregnancy and the Postpartum Period. JACC Case Rep. 2020 Jun; 2(6):847-851. View Abstract

  67. Tetralogy of Fallot. Cardiol Clin. 2020 Aug; 38(3):365-377. View Abstract

  68. Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects. Circ Cardiovasc Qual Outcomes. 2020 06; 13(6):e006311. View Abstract

  69. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association. Circulation. 2020 06 09; 141(23):e884-e903. View Abstract

  70. Recommendations for Multimodality Assessment of Congenital Coronary Anomalies: A Guide from the American Society of Echocardiography: Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2020 03; 33(3):259-294. View Abstract

  71. Creating a Multidisciplinary Pregnancy Heart Team. Curr Treat Options Cardiovasc Med. 2020 Jan 27; 22(1):3. View Abstract

  72. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease: A Report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol. 2020 02 18; 75(6):657-703. View Abstract

  73. Predictors and Trend of Ketoacidosis Hospitalization Rate in Type 2 Diabetes Mellitus Patients from 2006 to 2015 in Abruzzo Region, Italy. Clin Ter. 2020 Jan-Feb; 170(1):e53-e58. View Abstract

  74. Relation of Right Ventricular Dilation After Pulmonary Valve Replacement to Outcomes in Patients With Repaired Tetralogy of Fallot. Am J Cardiol. 2020 03 15; 125(6):977-981. View Abstract

  75. Implanted pacemaker and cardioverter-defibrillator in a patient with ectopia cordis. HeartRhythm Case Rep. 2020 Feb; 6(2):110-113. View Abstract

  76. Advanced Heart Failure Therapies for Adults With Congenital Heart Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 11 05; 74(18):2295-2312. View Abstract

  77. Surveillance and screening practices of New England congenital cardiologists for patients after the Fontan operation. Congenit Heart Dis. 2019 Nov; 14(6):1013-1023. View Abstract

  78. Echocardiographic surveillance in children after tetralogy of Fallot repair: Adherence to guidelines? Int J Cardiol. 2020 05 15; 307:31-35. View Abstract

  79. Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease. J Nucl Cardiol. 2021 08; 28(4):1395-1408. View Abstract

  80. Standardized outcomes in reproductive cardiovascular care: The STORCC initiative. Am Heart J. 2019 11; 217:112-120. View Abstract

  81. Planned vaginal delivery and cardiovascular morbidity in pregnant women with heart disease. Am J Obstet Gynecol. 2020 01; 222(1):77.e1-77.e11. View Abstract

  82. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e698-e800. View Abstract

  83. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e637-e697. View Abstract

  84. Academic Advancement in the Current Era: Integrating and Empowering Clinician Educators. J Am Coll Cardiol. 2019 02 12; 73(5):620-623. View Abstract

  85. Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 02 05; 73(4):457-476. View Abstract

  86. Myocardial fibrosis and its relation to adverse outcome in transposition of the great arteries with a systemic right ventricle. Int J Cardiol. 2018 Nov 15; 271:60-65. View Abstract

  87. State of the Art Management of Mechanical Heart Valves During Pregnancy. Curr Treat Options Cardiovasc Med. 2018 Nov 12; 20(12):102. View Abstract

  88. Preoperative Predictors of Death and Sustained Ventricular Tachycardia After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot Enrolled in the INDICATOR Cohort. Circulation. 2018 11 06; 138(19):2106-2115. View Abstract

  89. Diagnosing Pulmonary Embolism During Pregnancy: Which Test Is Best? Ann Intern Med. 2018 12 04; 169(11):810-811. View Abstract

  90. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. Eur Heart J. 2018 09 07; 39(34):3253-3261. View Abstract

  91. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy. Circulation. 2018 08 21; 138(8):782-792. View Abstract

  92. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 04 02; 73(12):e81-e192. View Abstract

  93. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 04 02; 73(12):1494-1563. View Abstract

  94. A Pilot Study of Inspiratory Muscle Training to Improve Exercise Capacity in Patients with Fontan Physiology. Semin Thorac Cardiovasc Surg. 2018 Winter; 30(4):462-469. View Abstract

  95. Predicting survival in adults with congenital heart disease: what are the odds? Heart. 2018 10; 104(20):1643-1644. View Abstract

  96. Usefulness of Pulmonary Arterial End-Diastolic Forward Flow Late After Tetralogy of Fallot Repair to Predict a "Restrictive" Right Ventricle. Am J Cardiol. 2018 06 01; 121(11):1380-1386. View Abstract

  97. Outcomes of Patients With Hypoplastic Left Heart Syndrome Reaching Adulthood After Fontan Palliation: Multicenter Study. Circulation. 2018 02 27; 137(9):978-981. View Abstract

  98. The growth and evolution of cardiovascular magnetic resonance: a 20-year history of the Society for Cardiovascular Magnetic Resonance (SCMR) annual scientific sessions. J Cardiovasc Magn Reson. 2018 01 31; 20(1):8. View Abstract

  99. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2018 05; 104(9):738-744. View Abstract

  100. Status of Early-Career Academic Cardiology: A Global Perspective. J Am Coll Cardiol. 2017 Oct 31; 70(18):2290-2303. View Abstract

  101. Outcomes and Costs of Cardiac Surgery in Adults with Congenital Heart Disease. Pediatr Cardiol. 2017 Oct; 38(7):1359-1364. View Abstract

  102. How to Image Repaired Tetralogy of Fallot. Circ Cardiovasc Imaging. 2017 05; 10(5). View Abstract

  103. P453 Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease. J Crohns Colitis. 2017 Feb 01; 11(suppl_1):S308-S309. View Abstract

  104. Liver health in adults with Fontan circulation: A multicenter cross-sectional study. J Thorac Cardiovasc Surg. 2017 03; 153(3):656-664. View Abstract

  105. Anticoagulation During Pregnancy: Evolving Strategies With a Focus on Mechanical Valves. J Am Coll Cardiol. 2016 10 18; 68(16):1804-1813. View Abstract

  106. Sarcopenia and osteoporosis in Portuguese centenarians. Eur J Clin Nutr. 2017 01; 71(1):56-63. View Abstract

  107. Evolution of hypertrophic cardiomyopathy in sarcomere mutation carriers. Heart. 2016 Nov 15; 102(22):1805-1812. View Abstract

  108. Acute and chronic malnutrition and their predictors in children aged 0-5 years in São Tomé: a cross-sectional, population-based study. Public Health. 2016 Nov; 140:91-101. View Abstract

  109. Left and right ventricular dyssynchrony and strains from cardiovascular magnetic resonance feature tracking do not predict deterioration of ventricular function in patients with repaired tetralogy of Fallot. J Cardiovasc Magn Reson. 2016 08 22; 18(1):49. View Abstract

  110. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients. J Heart Lung Transplant. 2017 Feb; 36(2):211-219. View Abstract

  111. Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group. J Am Coll Cardiol. 2016 Apr 26; 67(16):1956-64. View Abstract

  112. Cardiac magnetic resonance imaging characteristics and pregnancy outcomes in women with Mustard palliation for complete transposition of the great arteries. Int J Cardiol Heart Vasc. 2016 Mar; 10:54-59. View Abstract

  113. Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA. Eur Heart J Cardiovasc Imaging. 2017 Feb; 18(2):224-235. View Abstract

  114. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation. J Am Heart Assoc. 2016 Jan 11; 5(1). View Abstract

  115. Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot. JACC Cardiovasc Imaging. 2016 Jan; 9(1):1-10. View Abstract

  116. The Sophistication of Simplicity: Ventricular Function and Oximetry Predict Survival in Eisenmenger Syndrome. Circ Cardiovasc Imaging. 2015 Dec; 8(12). View Abstract

  117. Cardiovascular Management in Pregnancy: Antithrombotic Agents and Antiplatelet Agents. Circulation. 2015 Oct 06; 132(14):1354-64. View Abstract

  118. Imaging of congenital heart disease in adults. Eur Heart J. 2016 Apr 14; 37(15):1182-95. View Abstract

  119. Cardiac magnetic resonance markers of progressive RV dilation and dysfunction after tetralogy of Fallot repair. Heart. 2015 Nov; 101(21):1724-30. View Abstract

  120. Safety of Magnetic Resonance Imaging After Implantation of Stainless Steel Embolization Coils. Pediatr Cardiol. 2016 Jan; 37(1):62-7. View Abstract

  121. Assessment of difficulty in third impacted mandibular molar surgery: the Conti Scale. Minerva Stomatol. 2015 Aug; 64(4):177-88. View Abstract

  122. Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease. J Nucl Cardiol. 2016 Feb; 23(1):45-63. View Abstract

  123. Mechanical Heart Valves in Pregnancy: A Sticky Business. Circulation. 2015 Jul 14; 132(2):79-81. View Abstract

  124. Electronic medical record integration with a database for adult congenital heart disease: Early experience and progress in automating multicenter data collection. Int J Cardiol. 2015 Oct 01; 196:178-82. View Abstract

  125. Task Force 6: Pediatric Cardiology Fellowship Training in Adult Congenital Heart Disease. J Am Coll Cardiol. 2015 Aug 11; 66(6):723-31. View Abstract

  126. Task Force 6: Pediatric Cardiology Fellowship Training in Adult Congenital Heart Disease. SPCTPD/ACC/AAP/AHA. Circulation. 2015 Aug 11; 132(6):e91-8. View Abstract

  127. 2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs). J Am Coll Cardiol. 2015 Mar 13. View Abstract

  128. Haemodynamic impact of stent implantation for lateral tunnel Fontan stenosis: a patient-specific computational assessment. Cardiol Young. 2016 Jan; 26(1):116-26. View Abstract

  129. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transplant. 2015 Jul; 34(7):883-91. View Abstract

  130. Tricuspid valve regurgitation in congenitally corrected transposition of the great arteries and a left ventricle to pulmonary artery conduit. Ann Thorac Surg. 2015 Apr; 99(4):1348-56. View Abstract

  131. Relationship between Exercise Parameters and Noninvasive Indices of Right Ventricular Function in Patients with Biventricular Circulation and Systemic Right Ventricle. Congenit Heart Dis. 2015 Sep-Oct; 10(5):457-65. View Abstract

  132. Cardiac Calcifications in Adults with Congenital Heart Defects. Congenit Heart Dis. 2015 Sep-Oct; 10(5):396-402. View Abstract

  133. Resting heart rate influences right ventricular volume in repaired tetralogy of Fallot. Pediatr Cardiol. 2015 Apr; 36(4):813-20. View Abstract

  134. Relation of biventricular strain and dyssynchrony in repaired tetralogy of fallot measured by cardiac magnetic resonance to death and sustained ventricular tachycardia. Am J Cardiol. 2015 Mar 01; 115(5):676-80. View Abstract

  135. Heart failure in adult congenital heart disease: Emerging concepts with a focus on tetralogy of Fallot. Trends Cardiovasc Med. 2015 Jul; 25(5):422-32. View Abstract

  136. Energetic implications of vessel growth and flow changes over time in Fontan patients. Ann Thorac Surg. 2015 Jan; 99(1):163-70. View Abstract

  137. Rare case of undiagnosed supracardiac total anomalous pulmonary venous return in an adult. Circulation. 2014 Sep 30; 130(14):1205-7. View Abstract

  138. Durability of large diameter right ventricular outflow tract conduits in adults with congenital heart disease. Int J Cardiol. 2014 Aug 20; 175(3):455-63. View Abstract

  139. Integration of cardiac magnetic resonance imaging in pre-procedural planning and electroanatomical mapping for catheter ablation after a Fontan-Bjork correction of tricuspid atresia. Eur Heart J Cardiovasc Imaging. 2014 Nov; 15(11):1306. View Abstract

  140. Heart failure treatment in adults with congenital heart disease: where do we stand in 2014? Heart. 2014 Sep; 100(17):1329-34. View Abstract

  141. Challenges facing early career academic cardiologists. J Am Coll Cardiol. 2014 Jun 03; 63(21):2199-208. View Abstract

  142. Multimodality imaging guidelines for patients with repaired tetralogy of fallot: a report from the AmericanSsociety of Echocardiography: developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society for Pediatric Radiology. J Am Soc Echocardiogr. 2014 Feb; 27(2):111-41. View Abstract

  143. Fontan pathway growth: a quantitative evaluation of lateral tunnel and extracardiac cavopulmonary connections using serial cardiac magnetic resonance. Ann Thorac Surg. 2014 Mar; 97(3):916-22. View Abstract

  144. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014 Sep-Oct; 9(5):438-47. View Abstract

  145. Clinical research priorities in adult congenital heart disease. Int J Cardiol. 2014 Feb 15; 171(3):351-60. View Abstract

  146. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014 Feb; 100(3):247-53. View Abstract

  147. Cardiology Patient Page. Preeclampsia. Circulation. 2013 Oct 22; 128(17):e344-5. View Abstract

  148. Outcomes of adolescents and adults undergoing primary Fontan procedure. Am J Cardiol. 2013 Dec 15; 112(12):1938-42. View Abstract

  149. Cardiovascular magnetic resonance imaging predictors of pregnancy outcomes in women with coarctation of the aorta. Eur Heart J Cardiovasc Imaging. 2014 Mar; 15(3):299-306. View Abstract

  150. Cardiac magnetic resonance in adults with congenital heart disease. Methodist Debakey Cardiovasc J. 2013 Jul-Sep; 9(3):156-62. View Abstract

  151. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv. 2013 Jun; 6(3):301-10. View Abstract

  152. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy. Circ Cardiovasc Genet. 2013 Jun; 6(3):230-7. View Abstract

  153. Improving heart disease knowledge and research participation in adults with congenital heart disease (the Health, Education and Access Research Trial: HEART-ACHD). Int J Cardiol. 2013 Oct 09; 168(4):3236-40. View Abstract

  154. Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol. 2013 May 28; 61(21):2180-4. View Abstract

  155. Outcome predictors and implications for management of scimitar syndrome. Am Heart J. 2013 May; 165(5):770-7. View Abstract

  156. Shock-related anxiety and sexual function in adults with congenital heart disease and implantable cardioverter-defibrillators. Heart Rhythm. 2013 Jun; 10(6):805-10. View Abstract

  157. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013 Apr; 99(7):491-6. View Abstract

  158. Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Can J Cardiol. 2013 Jul; 29(7):866-72. View Abstract

  159. The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot. Int J Cardiol. 2013 Oct 03; 168(3):1847-52. View Abstract

  160. Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interv. 2013 Feb; 6(1):59-67. View Abstract

  161. Assessment of the cerebral circulation in adults with coarctation of the aorta. Congenit Heart Dis. 2013 Jul-Aug; 8(4):289-95. View Abstract

  162. Aortic root dilatation in adults with surgically repaired tetralogy of fallot: a multicenter cross-sectional study. Circulation. 2013 Jan 15; 127(2):172-9. View Abstract

  163. Diagnosis and management of ebstein anomaly of the tricuspid valve. Curr Treat Options Cardiovasc Med. 2012 Dec; 14(6):594-607. View Abstract

  164. Correlation of exercise response in repaired coarctation of the aorta to left ventricular mass and geometry. Am J Cardiol. 2013 Feb 01; 111(3):406-11. View Abstract

  165. QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly. Eur Heart J. 2013 Jan; 34(3):191-200. View Abstract

  166. Occult spinal dysraphism in obstetrics: a case report of caesarean section with subarachnoid anaesthesia after remifentanil intravenous analgesia for labour. Case Rep Obstet Gynecol. 2012; 2012:472482. View Abstract

  167. Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis. Int J Cardiol. 2013 Sep 01; 167(5):1918-23. View Abstract

  168. Coronary Arteries in Childhood Heart Disease: Implications for Management of Young Adults. J Clin Exp Cardiolog. 2012 Jun 15; (Suppl 8). View Abstract

  169. Congenital Heart Defects in Adults : A Field Guide for Cardiologists. J Clin Exp Cardiolog. 2012 Jun 15; (Suppl 8). View Abstract

  170. Rationale and design of an International Multicenter Registry of patients with repaired tetralogy of Fallot to define risk factors for late adverse outcomes: the INDICATOR cohort. Pediatr Cardiol. 2013 Jan; 34(1):95-104. View Abstract

  171. Advanced pulmonary vascular therapy for adults with congenital heart disease: potential for progress. J Card Fail. 2012 May; 18(5):385-6. View Abstract

  172. Acute dyspnea in a young man with an old sternotomy. Congenit Heart Dis. 2012 Sep-Oct; 7(5):E73-7. View Abstract

  173. Experimental and numeric investigation of Impella pumps as cavopulmonary assistance for a failing Fontan. J Thorac Cardiovasc Surg. 2012 Sep; 144(3):563-9. View Abstract

  174. Pathophysiology of chronic venous insufficiency in adults with a Fontan circulation (a pre-defined substudy of the CALF investigation). Int J Cardiol. 2013 Apr 30; 165(1):41-5. View Abstract

  175. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus. 2011 Oct; 20(11):1187-92. View Abstract

  176. Discovery and management of diaphragmatic hernia related to abandoned epicardial pacemaker wires in a pregnant woman with {S,L,L} transposition of the great arteries. Congenit Heart Dis. 2012 Mar-Apr; 7(2):183-8. View Abstract

  177. Liver disease in the patient with Fontan circulation. Congenit Heart Dis. 2011 May-Jun; 6(3):190-201. View Abstract

  178. Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot. Am J Cardiol. 2011 Apr 15; 107(8):1215-20. View Abstract

  179. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation. 2011 Jan 25; 123(3):242-8. View Abstract

  180. Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy. Eur J Echocardiogr. 2011 Feb; 12(2):131-9. View Abstract

  181. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010 Aug 31; 122(9):868-75. View Abstract

  182. The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J Am Coll Cardiol. 2010 Jul 06; 56(2):144-50. View Abstract

  183. Predictors of long-term adverse outcomes in patients with congenital coronary artery fistulae. Circ Cardiovasc Interv. 2010 Apr; 3(2):134-9. View Abstract

  184. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg. 2009 Aug; 88(2):558-63; discussion 563-4. View Abstract

  185. Images in cardiovascular medicine. Right aortic arch with aberrant left innominate artery: a rare vascular ring. Circulation. 2009 Jul 21; 120(3):264-5. View Abstract

  186. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation. 2009 Mar 17; 119(10):1370-7. View Abstract

  187. Feasibility of dobutamine stress cardiovascular magnetic resonance imaging in children. J Magn Reson Imaging. 2009 Feb; 29(2):313-9. View Abstract

  188. Right ventricular hypertrophy with early dysfunction: A proteomics study in a neonatal model. J Thorac Cardiovasc Surg. 2009 May; 137(5):1146-53. View Abstract

  189. Multicenter research in adult congenital heart disease. Int J Cardiol. 2008 Sep 26; 129(2):155-9. View Abstract

  190. Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth. 2008 Apr; 17(2):130-6. View Abstract

  191. Clinical applications of cardiovascular magnetic resonance in congenital heart disease. Magn Reson Imaging Clin N Am. 2007 Nov; 15(4):565-77, vi. View Abstract

  192. Right heart dilatation in adults: congenital causes. AJR Am J Roentgenol. 2007 Sep; 189(3):592-601. View Abstract

  193. Clinical applications of cardiovascular magnetic resonance in congenital heart disease. Cardiol Clin. 2007 Feb; 25(1):97-110, vi. View Abstract

  194. Cardiac magnetic resonance imaging evaluation of sinus venosus defects: comparison to surgical findings. Pediatr Cardiol. 2007 Jan-Feb; 28(1):51-6. View Abstract

  195. Unusual cardiomyopathies: ventricular noncompaction and takotsubo cardiomyopathy. Rev Cardiovasc Med. 2006; 7(3):111-8. View Abstract

  196. Highlights from the American College of Cardiology Annual Scientific Session 2005: March 6 to 9, 2005, Orlando, Florida. Am Heart J. 2005 Jun; 149(6):1009-19. View Abstract

  197. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics. 2005 Jan; 115(1):e15-9. View Abstract

  198. Highlights from the American College of Cardiology Annual Scientific Sessions 2004: March 9-12, 2004. Am Heart J. 2004 Aug; 148(2):254. View Abstract

  199. Measures of cardiac repolarization and body position in infants. Clin Pediatr (Phila). 2003 Jan-Feb; 42(1):67-70. View Abstract

  200. Hypothyroidism in house officers. Lancet. 2002 Sep 14; 360(9336):879. View Abstract

  201. Hyperlipidemia in children and adolescents. Am Heart J. 2001 Sep; 142(3):433-9. View Abstract

  202. Obesity and insulin resistance in young people. Am Heart J. 2001 Sep; 142(3):440-4. View Abstract

  203. Lymphoscintigraphic evaluation in patients after erysipelas. Lymphology. 2000 Dec; 33(4):177-80. View Abstract

  204. [Preterm premature rupture of membranes in the 19th week of pregnancy. A clinical case]. Minerva Ginecol. 1999 Apr; 51(4):139-43. View Abstract

  205. Hyaluronate receptor CD44 is expressed by astrocytes in the adult chicken and in astrocyte cell precursors in early development of the chick spinal cord. Eur J Histochem. 1999; 43(1):29-38. View Abstract

  206. Antisperm antibodies in cryptorchidism before and after surgery. J Urol. 1998 Nov; 160(5):1834-7. View Abstract

  207. Phosphorylated and non-phosphorylated neurofilament epitopes are co-distributed in the fish Mauthner axon. Cell Mol Biol (Noisy-le-grand). 1998 Jun; 44(4):605-14. View Abstract

  208. [Review on renal calculosis in pregnancy]. Clin Ter. 1997 Dec; 148(12):667-73. View Abstract

  209. [Causes for transfer of obstetric patients to an intensive care unit (1990-19960]. Minerva Ginecol. 1997 Oct; 49(10):443-6. View Abstract

  210. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 1996 Jan; 41(1):172-9. View Abstract

  211. [Relapse modalities in medulloblastoma]. Pediatr Med Chir. 1994 May-Jun; 16(3):241-5. View Abstract

  212. [Is intraoperative cholangiography always indicated during videolaparoscopic cholecystectomy?]. Ann Ital Chir. 1994 May-Jun; 65(3):335-43; discussion 344. View Abstract

  213. Long-term follow-up of patients initially diagnosed with syndrome X. Am J Cardiol. 1993 Mar 15; 71(8):669-73. View Abstract

  214. Unstable angina: role of silent ischemia and total ischemic time (silent plus painful ischemia), a 6-year follow-up. J Am Coll Cardiol. 1992 May; 19(6):1173-9. View Abstract

  215. Characterization and long-term prognosis of patients with effort-induced silent myocardial ischaemia. Eur Heart J. 1992 Apr; 13(4):457-63. View Abstract

  216. [Head trauma in a general surgery department: observations, diagnostic and therapeutic indications]. Ann Ital Chir. 1992 Mar-Apr; 63(2):163-7; discussion 168. View Abstract

  217. Coronary artery loops and myocardial ischemia. Am Heart J. 1991 Jul; 122(1 Pt 1):225-6. View Abstract

  218. Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals. Cardiovasc Drugs Ther. 1990 Aug; 4 Suppl 5:905-8. View Abstract

  219. [Acute myocardial infarct in puerperium: description of 2 cases]. Cardiologia. 1988 Oct; 33(10):995-8. View Abstract

  220. [The negative exertion test in the natural history of ischemic cardiopathy. Personal cases and review of the literature]. Cardiologia. 1986 Jan; 31(1):43-6. View Abstract

  221. Clinical and neuropsychological correlates of cerebral ventricular enlargement in schizophrenia. J Psychiatr Res. 1985; 19(4):587-96. View Abstract

  222. Serum ferritin in beta-thalassaemia intermedia. Scand J Haematol. 1984 Jan; 32(1):83-7. View Abstract

While in medical school at the University of Vermont, my mentor brought me to Boston Children’s Hospital to observe complex congenital cardiac surgery in a newborn. Watching that intricate procedure, I could not stop thinking about what the future would hold for that young child. Working at Boston Children’s Hospital allows me to interact with so many amazing adults who have grown up with congenital heart disease. The advances in the field have been great over the past two decades; and I am fortunate to be a member of the Boston Adult Congenital Heart Disease Program to help further the mission to improve the long-term outcomes in adults with congenital heart disease.

BESbswy